Renix's technology offers a fundamental change to the ion exchange process. Businesses that rely on ion exchange represent over $US 700 billion in goods produced annually in the USA and spend over $US 50 billion in annual capital. These businesses are found in diverse sectors within industry, including food and beverage, nutrition, pharmaceuticals, power generation, mining and specialty chemicals. Renix is located at the Stiller Centre, University of Western Ontario Research Park in London, Ontario.

Renix's Continuous Fluidized Ion Exchange (CFIX) process represents an evolution from the commonly employed batch and semi-batch ion exchange. It is the only commercially available ion exchange process that offers simultaneous, concurrent resin regeneration. This patented process has been demonstrated at the technical and pilot scale at the University of Western Ontario. Results have shown that CFIX can offer significant competitive advantages when compared to the widely used batch type processes. For a batch system of similar capacity, CFIX can offer equivalent or better performance at lower operating costs, higher productivity and significantly lower CAPEX.

Renix plans to build and sell CFIX systems. It is currently in the commercial demonstration stage, working with potential customers of existing ion exchange processes to help improve their competitiveness. Renix's technology also opens the door to new economic applications for ion exchange where prior ion exchange technologies could not compete with other processing alternatives.